You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -5,022.8% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -3.9 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 186.8 | 0.0 |
| Price / Book value | 4.1 |
| Latest | Forecast | |
|---|---|---|
| Revenue | -28.7% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-05-31 | 1.34 | -2.01 | -8.67p | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2016-05-31 | 0.43 | -9.01 | -12.97p | -10.1 | 0.0 | n/a | n/a | 0.0% |
| 2017-05-31 | 0.21 | -5.32 | -9.84p | -14.3 | 0.0 | n/a | n/a | 0.0% |
| 2018-05-31 | 0.24 | -6.34 | -11.41p | -11.1 | 0.0 | n/a | n/a | 0.0% |
| 2019-05-31 | 0.17 | -8.55 | -12.97p | -7.1 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-05-31 | 0.00 | 0.00 | 0.00p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-05-31 | 0.00 | 0.00 | 0.00p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Oncimmune funded into 2021 with new EUR 8.5m facility Sharecast News | 20 Sep |
|---|---|
| Oncimmune partners with R-Pharm to take 'EarlyCDT Lung' to Russia Sharecast News | 04 Jul |
| Oncimmune sells US operations to and partners with Biodesix Sharecast News | 28 Jun |
| Notice of AGM and Posting of Annual Report | 04-Nov-19 14:47 |
|---|---|
| Draw down of second tranche of credit facility | 04-Nov-19 07:04 |
| Oncimmune and Biodesix seal deal | 01-Nov-19 07:28 |
| Final Results | 31-Oct-19 07:07 |
| Notice of Full Year Results ended May 2019 | 25-Oct-19 07:05 |